Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder.

Whether magnetic resonance imaging studies can provide useful information to clinicians who treat people with major depressive disorder remains to be established. There are, however, several recent findings that suggest that likelihood of response may be predicted by imaging findings. For example, morphometric studies have examined whether hippocampus volume is associated with clinically meaningful outcomes such as response to treatment. In general, patients who remit have larger pretreatment hippocampus volumes bilaterally compared with those who do not remit. There are similar preliminary findings for the anterior cingulate cortex. There are also a number of functional imaging studies that have identified different activity patterns in those who are likely to respond to treatment compared with those who are not. Using positron emission tomography, investigators have reported different patterns of response to treatment in those treated with medication compared with those treated with psychotherapy. Some of the potential barriers to the routine use of imaging in psychiatric practice are reviewed briefly.

[1]  M. Brammer,et al.  Neuroanatomy of verbal working memory as a diagnostic biomarker for depression , 2008, Neuroreport.

[2]  C. Martini,et al.  Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. , 2008, Journal of affective disorders.

[3]  Glenda M. MacQueen,et al.  Posterior Hippocampal Volumes Are Associated with Remission Rates in Patients with Major Depressive Disorder , 2008, Biological Psychiatry.

[4]  Faith M. Gunning-Dixon,et al.  Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. , 2009, Journal of affective disorders.

[5]  John Suckling,et al.  Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment , 2007, Biological Psychiatry.

[6]  Richard S. J. Frackowiak,et al.  Navigation-related structural change in the hippocampi of taxi drivers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Peter Herscovitch,et al.  Regional cerebral glucose utilization in patients with a range of severities of unipolar depression , 2002, Biological Psychiatry.

[8]  A. Berghold,et al.  Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  Causes, relationships and explanations: the power and limitations of observational longitudinal imaging studies. , 2008, Current opinion in neurology.

[10]  P Videbech,et al.  The Danish PET/depression project: PET findings in patients with major depression , 2001, Psychological Medicine.

[11]  Deborah A Yurgelun-Todd,et al.  Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study , 2000, Biological Psychiatry.

[12]  R. DeRubeis,et al.  Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms , 2008, Nature Reviews Neuroscience.

[13]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[14]  P. Ryvlin,et al.  Magnetic resonance imaging in clinical trials , 2008, Current opinion in neurology.

[15]  S. Rizvi,et al.  Current approved options for treating patients with multiple sclerosis , 2004, Neurology.

[16]  D. Steffens,et al.  Hippocampal volume and antidepressant response in geriatric depression , 2002, International journal of geriatric psychiatry.

[17]  M. Fox,et al.  Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging , 2007, Nature Reviews Neuroscience.

[18]  Abraham Z. Snyder,et al.  A default mode of brain function: A brief history of an evolving idea , 2007, NeuroImage.

[19]  Helen S Mayberg,et al.  Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. , 2007, The American journal of psychiatry.

[20]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[21]  T. Uzbay,et al.  Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  K. Felmingham,et al.  Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder , 2007, Psychological Medicine.

[23]  T. Wassink,et al.  Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. , 2006, Archives of general psychiatry.

[24]  N. Gervasoni,et al.  Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode , 2005, Neuropsychobiology.

[25]  Rene Hen,et al.  Adult hippocampal neurogenesis in depression , 2007, Nature Neuroscience.

[26]  M. Lowe,et al.  Activity and Connectivity of Brain Mood Regulating Circuit in Depression: A Functional Magnetic Resonance Study , 2005, Biological Psychiatry.

[27]  M. Thase,et al.  Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. , 2006, The American journal of psychiatry.

[28]  J. Whitwell,et al.  Longitudinal imaging: change and causality , 2008, Current opinion in neurology.

[29]  Jeffrey H. Meyer,et al.  Applying Neuroimaging Ligands to Study Major Depressive Disorder Neuroimaging Contributions to Monoamine Regulation in Mdd , 2022 .

[30]  Chien-Te Lee,et al.  Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. , 2008, Journal of psychiatric research.

[31]  Vincent A Magnotta,et al.  Hippocampal volume and 2-year outcome in depression. , 2008, The British journal of psychiatry : the journal of mental science.

[32]  G. MacQueen,et al.  Neurobiological Factors Linking Personality Traits and Major Depression , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[33]  L. Kirmayer,et al.  The persistence of mind-brain dualism in psychiatric reasoning about clinical scenarios. , 2006, The American journal of psychiatry.

[34]  Ivan Toni,et al.  Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. , 2008, Brain : a journal of neurology.

[35]  F. Taneli,et al.  Serum brain‐derived neurotrophic factor levels in conversion disorder: Comparative study with depression , 2007, Psychiatry and clinical neurosciences.

[36]  Fred H. Gage,et al.  An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus , 2007, Proceedings of the National Academy of Sciences.

[37]  Vinod Menon,et al.  Functional connectivity in the resting brain: A network analysis of the default mode hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Sung-Cheng Huang,et al.  Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. , 2002, Archives of general psychiatry.

[39]  S. Rombouts,et al.  Consistent resting-state networks across healthy subjects , 2006, Proceedings of the National Academy of Sciences.

[40]  Hans-Jürgen Möller,et al.  Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. , 2008, Journal of psychiatry & neuroscience : JPN.

[41]  R. Duman,et al.  VEGF as a potential target for therapeutic intervention in depression. , 2008, Current opinion in pharmacology.

[42]  R A Bryant,et al.  Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety , 2009, Molecular Psychiatry.

[43]  John D E Gabrieli,et al.  Amygdala reactivity to emotional faces predicts improvement in major depression , 2005, Neuroreport.

[44]  A. Gjedde,et al.  The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions‐of‐interest analysis , 2002, Acta psychiatrica Scandinavica.

[45]  M. Lowe,et al.  Antidepressant Effect on Connectivity of the Mood-Regulating Circuit: An fMRI Study , 2005, Neuropsychopharmacology.

[46]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[47]  Dimitris Samaras,et al.  Exploiting Temporal Information in Functional Magnetic Resonance Imaging Brain Data , 2005, MICCAI.

[48]  Robin M. Murray,et al.  Neural Responses to Sad Facial Expressions in Major Depression Following Cognitive Behavioral Therapy , 2008, Biological Psychiatry.

[49]  F. Taneli,et al.  Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[50]  Benjamin J. Shannon,et al.  Coherent spontaneous activity identifies a hippocampal-parietal memory network. , 2006, Journal of neurophysiology.

[51]  G. Glover,et al.  Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus , 2007, Biological Psychiatry.

[52]  B. Turetsky,et al.  Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. , 2005, Archives of general psychiatry.

[53]  C. Pittenger,et al.  Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms , 2008, Neuropsychopharmacology.

[54]  V. Calhoun,et al.  Interrater and intermethod reliability of default mode network selection , 2009, Human brain mapping.

[55]  M. Greicius Resting-state functional connectivity in neuropsychiatric disorders , 2008, Current opinion in neurology.

[56]  P. Buckley,et al.  Association Between Brain-Derived Neurotrophic Factor Val66met Gene Polymorphism and Progressive Brain Volume Changes in Schizophrenia , 2009 .

[57]  Karl J. Friston,et al.  Functional Connectivity: The Principal-Component Analysis of Large (PET) Data Sets , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  Maurizio Corbetta,et al.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  A. Hariri,et al.  Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. , 2009, The American journal of psychiatry.

[60]  Stephen M. Smith,et al.  fMRI resting state networks define distinct modes of long-distance interactions in the human brain , 2006, NeuroImage.

[61]  Tom Johnstone,et al.  Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. , 2009, The American journal of psychiatry.

[62]  Richard J. Davidson,et al.  A Functional Magnetic Resonance Imaging Predictor of Treatment Response to Venlafaxine in Generalized Anxiety Disorder , 2008, Biological Psychiatry.

[63]  G. MacQueen,et al.  A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[64]  Michael Marriott,et al.  Lower hippocampal volume in patients suffering from depression: a meta-analysis. , 2004, The American journal of psychiatry.

[65]  Hans-Jürgen Möller,et al.  Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. , 2004, The Journal of clinical psychiatry.